Replies to post #905 on Chad Therapeutics, Inc. (fka CHADQ)

[MightySam]

Looks like it. Great opportunity here. Im am out of powder. if not, i would have bought more here. It is holding gains. Good sign

[hedge_fun]

The website is NOT the public company website.......

I got this email earlier, after inquiring on the website. I was curious as to why CHADQ filed in 2009 that it had CEASED OPERATIONS, but the website suggest OPERATIONS have commenced.

fromMulroy, Michael [e-mail]
[e-mail]

cc"Wiltsie, Kimberly" <[e-mail]>

dateMon, Aug 1, 2011 at 2:47 PM
subjectFW: CHAD Therapeutics - USA:
Important mainly because of the words in the message.

hide details 2:47 PM (1 hour ago)

Dear XXXXXX,

I am responding to your inquiry with the Inovo/Chad Therapeutics
customer service department regarding Chad Therapeutics, Inc. stock.

Inovo, Inc. acquired the conserving device assets of Chad Therapeutics
on February 15, 2008. Under this agreement, Inovo also purchased the
name "Chad Therapeutics". Inovo still uses this name to market certain
products.

Chad Therapeutics, Inc., the company that issued publicly traded shares,
I believe filed for Chapter 7 Bankruptcy protection in 2008 or 2009.
Either way, although Inovo uses the name Chad Therapeutics, we are a
privately held company and in no way affiliated with Chad Therapeutics,
Inc.

Thank you,

Mike Mulroy
Chief Operating Officer
Inovo, Inc.



On January 5, 2009, CHAD Therapeutics, Inc. (the “Company”) filed a petition in the United States Bankruptcy Court for the Central District of California under Chapter 7 of the United States Bankruptcy Code (the “Bankruptcy Petition”). The Company has ceased conducting business. David R. Hagen has been appointed as the bankruptcy trustee and can be contacted at 6320 Canoga Avenue, Suite 1400, Woodland Hills, California 91316.
For additional information regarding the Company’s January 5, 2009 Bankruptcy Petition, please contact Harris L. Cohen, Esq., at 5305 Andasol Ave., Encino, California 91316.


http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=6429707


On February 19, 2008, CHAD Therapeutics, Inc. (the “ Company ”) issued a press release announcing that it closed the sale of assets related to CHAD’s oxygen conserving business to Inovo, Inc., for $5.25 million in cash, pursuant to an asset purchase agreement dated November 16, 2007. A copy of the Company’s press release is incorporated herein by reference and is furnished as Exhibit 99.1 to this report.


http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=5744307